EVANSTON, Ill., Oct. 31 /PRNewswire-FirstCall/ -- Northfield Laboratories Inc. announced today that Steven A. Gould, M.D., Chairman and Chief Executive Officer, will be presenting at the Rodman & Renshaw Techvest 7th Annual Healthcare Conference in New York on Monday, November 7, 2005 at 12:40 p.m. ET. Interested investors may access the live webcast of the presentation at http://www.northfieldlabs.com. A replay of the presentation will be available and will be archived for two weeks.
About Northfield Laboratories
Northfield Laboratories Inc. is a leader in developing an oxygen-carrying resuscitative fluid, PolyHeme(R), for the treatment of urgent, large volume blood loss in trauma and resultant surgical settings. PolyHeme(R) is a solution of chemically modified human hemoglobin that requires no cross matching and is therefore compatible with all blood types. It has a shelf life of over 12 months. Enrollment is currently underway in a pivotal Phase III trial of PolyHeme(R) beginning in the pre-hospital setting. For further information, visit http://www.northfieldlabs.com.
Sophia H. Twaddell Vice President, Corporate Communications (847) 864-3500 stwaddell@northfieldlabs.com Sharon L. Weinstein Director, Investor Relations Noonan Russo (212) 845-4271 sharon.weinstein@eurorscg.com
Northfield Laboratories Inc.
CONTACT: Sophia H. Twaddell, Vice President, Corporate Communications,Northfield Laboratories, +1-847-864-3500, stwaddell@northfieldlabs.com;Sharon L. Weinstein, Director, Investor Relations, Noonan Russo,+1-212-845-4271, sharon.weinstein@eurorscg.com, for Northfield Laboratories
Web site: http://www.northfieldlabs.com/
